SCHEDULE 13G/A: Camber Capital Management and Stephen DuBois File Amended Schedule 13G for Solid Biosciences Inc., Reporting Zero Ownership

Camber Capital Management LP and Stephen DuBois have filed an amended Schedule 13G for Solid Biosciences Inc., indicating they no longer beneficially own any shares as of December 31, 2024.

Summary

• Camber Capital Management LP and Stephen DuBois filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership of Common Stock of Solid Biosciences Inc.
• As of December 31, 2024, both Camber Capital Management LP and Stephen DuBois reported 0 shares beneficially owned, representing 0% of the class.
• The filing states that the securities were not acquired and are not held for the purpose of changing or influencing the control of Solid Biosciences Inc.
• The filing was made pursuant to Rule 13d-1(b) of the Securities Exchange Act of 1934.

Sentiment

Score: 5

Explanation: The document is a factual regulatory filing (Schedule 13G Amendment No. 1) reporting a change in beneficial ownership to 0%, which is a neutral disclosure in itself, though the market may interpret the reduction in stake.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Provides transparency regarding significant ownership changes by institutional investors.

Key Dates

Keywords

Solid Biosciences Inc., SBLD, Schedule 13G, Camber Capital Management LP, Stephen DuBois, beneficial ownership, common stock, SEC filing